SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LEXG-Lexicon Genetics -- Ignore unavailable to you. Want to Upgrade?


To: rkrw who wrote (233)3/16/2010 7:36:39 PM
From: Arthur Radley  Respond to of 254
 
mffais.com

On a cursory look, it appears that funds have been adding share lately....still the price drop with this offering has been fairly large.

From their case studies.....no direct biotechs but there was the medical device maker and the Brazil dental firm.

I'm going to make a visit to their HQ this week......I want to know more about their vision. I have spoken with the Investor Relation director.....he is a Phd guy, but I want to look them in the eye..............I doubled down on the stock today, so I now have a vested interest in seeing if Invus knows what they are doing...........as you say.........Insane---- or savvy investors.



To: rkrw who wrote (233)3/24/2010 9:29:20 PM
From: Arthur Radley  Respond to of 254
 
blogs.wsj.com

Nice mention of LXRX and a couple more biotechs....in the Wall Street Journal blog.